The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 01, 2008
Filed:
May. 17, 1995
Paul A. Luciw, Davis, CA (US);
Dino Dina, San Francisco, CA (US);
Kathelyn Steimer, Benicia, CA (US);
Ray Sanchez Pescador, Oakland, CA (US);
Carlos George-nascimento, Danville, CA (US);
Deborah Parkes, Oakland, CA (US);
Rob Hallewell, San Francisco, CA (US);
Philip J. Barr, Oakland, CA (US);
Martha Truett, Oakland, CA (US);
Paul A. Luciw, Davis, CA (US);
Dino Dina, San Francisco, CA (US);
Kathelyn Steimer, Benicia, CA (US);
Ray Sanchez Pescador, Oakland, CA (US);
Carlos George-Nascimento, Danville, CA (US);
Deborah Parkes, Oakland, CA (US);
Rob Hallewell, San Francisco, CA (US);
Philip J. Barr, Oakland, CA (US);
Martha Truett, Oakland, CA (US);
Novartis Vaccines and Diagnostics, Inc., Emeryville, CA (US);
Abstract
Polynucleotide sequences are provided for the diagnosis of the presence of retroviral infection in a human host associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome, for expression of polypeptides and use of the polypeptides to prepare antibodies, where both the polypeptides and antibodies may be employed as diagnostic reagents or in therapy, e.g., vaccines and passive immunization. The sequences provide detection of the viral infectious agents associated with the indicated syndromes and can be used for expression of antigenic polypeptides.